Lu, Ching-Lan

Publications

Sort by

Co-Author Network

Combination therapy with anti-HIV-1 antibodies maintains viral suppression. Nature. 2018 Academic Article GET IT
Times cited: 359
Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117. The Journal of experimental medicine. 2018 Academic Article GET IT
Times cited: 81
Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo. Cell. 2017 Academic Article GET IT
Times cited: 104
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption. Nature. 2016 Academic Article GET IT
Times cited: 371
Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo. Science (New York, N.Y.). 2016 Academic Article GET IT
Times cited: 283
Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice. Cell. 2014 Academic Article GET IT
Times cited: 321